PPPurple Biotech Ltd. PPBT NASDAQ · Healthcare · Israel
$1.56 -6.59% -$0.11
- Market cap
- $215.4K
- Enterprise value
- -$3.99M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- -
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -245.1%
- Gross margin
- -
- Net margin
- -
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- -0.55
- Free float
- 94.5%
About the company
Purple Biotech Ltd. (PPBT) is a biopharmaceutical company specializing in the development of drug products for the treatment of rare diseases and oncological conditions. The company focuses on researching and developing innovative therapeutic approaches that can improve the quality of life for patients with these serious diseases. Purple Biotech emphasizes the use of biotechnologies and new treatment methods with the potential to change the way diseases are treated. The company responds to the demand for new treatment options for rare diseases and oncological conditions. Shares of Purple Biotech Ltd. (PPBT) can be an interesting choice for investors tracking the biopharmaceutical and innovation sector.
Sector
Healthcare
Industry
Biotechnology
CEO
Isaac Israel
Employees
10
Headquarters
Rehovot
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What to watch: It missed profit estimates 5 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $4.27M against $66.0K.
- What to watch: It passes only 3 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number